Aviva’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$412K Buy
17,691
+7,443
+73% +$232K ﹤0.01% 781
2025
Q4
$454K Buy
10,248
+3,431
+50% +$193K ﹤0.01% 826
2025
Q3
$499K Sell
6,817
-1,793
-21% -$117K ﹤0.01% 748
2025
Q2
$528K Sell
8,610
-672
-7% -$37.5K ﹤0.01% 701
2025
Q1
$539K Sell
9,282
-2,227
-19% -$141K ﹤0.01% 785
2024
Q4
$614K Sell
11,509
-5,348
-32% -$262K ﹤0.01% 682
2024
Q3
$734K Sell
16,857
-5,361
-24% -$179K ﹤0.01% 648
2024
Q2
$621K Sell
22,218
-714
-3% -$18.8K ﹤0.01% 742
2024
Q1
$617K Sell
22,932
-1,440
-6% -$41K ﹤0.01% 835
2023
Q4
$683K Buy
+24,372
New +$576K ﹤0.01% 747

Other funds holding DOCS

Aviva's DOCS Position: Q1 2026 in Review

Aviva increased its Doximity (DOCS) stake by 73% in Q1 2026, buying an estimated $232K and bringing the position to 17,691 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Aviva first reported a position in DOCS in Q4 2023 and has held it in 10 quarters since. The position peaked at $734K in Q3 2024. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Aviva held 17,691 shares of Doximity worth $412K as of Q1 2026.
  • Aviva bought 7,443 Doximity shares in Q1 2026, an estimated $232K.
  • Doximity made up ﹤0.01% of Aviva's portfolio in Q1 2026, its #781 holding.
  • Aviva first reported a position in Doximity in Q4 2023 and has held it in 10 quarters since.
  • Aviva's Doximity position peaked at $734K in Q3 2024.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.